Status:
COMPLETED
A Journey to Balance: Development and Validation of Individualized Life Balance Intervention for Depression
Lead Sponsor:
Chung Shan Medical University
Conditions:
Depression Disorders
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The goal of this clinical intervention study is to enhance life balance in community-dwelling individuals with depression. The main question it aims to answer is: Can an individualized life balance i...
Eligibility Criteria
Inclusion
- Diagnosed with depression by a psychiatrist.
- Assessed by a psychiatrist to be in a non-acute phase, approximately 4-8 weeks or more post-onset.
- Adults aged 20 or above with independent behavioral capacity.
- Literate, with basic cognitive function.
Exclusion
- Diagnosis of schizophrenia spectrum and other psychotic disorders, bipolar and related disorders, substance-related and addictive disorders, neurodevelopmental disorders, neurocognitive disorders, or substance/medication-induced depressive disorders.
- Significant physical illnesses requiring active and long-term treatment, such as cancer, cerebrovascular disease (stroke), spinal cord injury, congenital or genetic diseases, chronic renal failure, systemic autoimmune diseases, or burns.
- Lack of willingness to participate in the study.
Key Trial Info
Start Date :
September 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT06975098
Start Date
September 23 2024
End Date
June 30 2025
Last Update
August 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chung Shan Medical University Hospital
Taichung, Taiwan